Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients with Unresectable Locally Advanced or Metastatic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05620134
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:07.897847+00:00
Published At
2024-10-15T00:00:00+00:00
Record Updated At
2024-10-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer", "Tumor, Solid", "Advanced Solid Tumor", "Metastatic Cancer", "Melanoma", "Colorectal Cancer", "Non-small Cell Lung Cancer", "Small-cell Lung Cancer", "Urothelial Carcinoma", "Squamous Cell Carcinoma of Head and Neck", "Luminal Breast Cancer", "Triple Negative Breast Cancer", "Clear Cell Renal Cell Carcinoma", "Papillary Renal Cell Carcinoma", "Gastric Adenocarcinoma", "GastroEsophageal Cancer", "Squamous Cell Carcinoma Skin", "Pancreatic Adenocarcinoma", "Hepatocellular Carcinoma", "Colorectal Adenocarcinoma", "Epithelial Ovarian Cancer", "Thyroid Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-15"
protocolSection.identificationModule.nctId
"NCT05620134"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, Multicenter, Open Label, Dose Escalation \u0026 Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients with Unresectable Locally Advanced or Metastatic Cancer"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cancer (protocolSection.conditionsModule.conditions)
  • Tumor, Solid (protocolSection.conditionsModule.conditions)
  • Advanced Solid Tumor (protocolSection.conditionsModule.conditions)
  • Metastatic Cancer (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Small-cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of Head and Neck (protocolSection.conditionsModule.conditions)
  • Luminal Breast Cancer (protocolSection.conditionsModule.conditions)
  • Triple Negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Clear Cell Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Papillary Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Gastric Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • GastroEsophageal Cancer (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma Skin (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Colorectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Epithelial Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Thyroid Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.